Lupin Pharmaceuticals Inc. 2024-11-27 Health serious FDA
Health · FDA · Recall #FDA-D-0054-2025
Ramipril Capsules USP 10 mg, a) 90 count (NDC 68180-591-09), b) 100 count NDC… Recall
Issued November 27, 2024 · Lupin Pharmaceuticals Inc.
In November 2024, Lupin Pharmaceuticals Inc. recalled the Ramipril Capsules USP 10 mg, a) 90 count (NDC 68180-591-09), b) 100 count NDC…, a serious health recall reported by the FDA. Affected owners are eligible for a voluntary. Here is what the hazard is and exactly what to do about it.
Compiled by Maya Ellison, RecallCheckr
What this means for you
CGMP Deviations: Active pharmaceutical ingredient was sourced from an unapproved vendor
What you should do
- 1 Stop using Ramipril Capsules USP 10 mg, a) 90 count (NDC 68180-591-09), b) 100 count NDC… right away.
- 2 Set it aside where it won't be used by mistake.
- 3 Contact Lupin Pharmaceuticals Inc. to arrange your voluntary. See the official notice below for contact details.
- 4 Keep the product until your remedy is fully processed. You may need it.
Official remedy (Voluntary):
Recall details
- Brand
- Lupin Pharmaceuticals Inc.
- Category
- Health
- Recall date
- November 27, 2024
- Units affected
- Not reported
- Sold at
- Product was distributed to 30 wholesalers/distributors who may have further distributed the product nationwide.
- Recall number
- FDA-D-0054-2025
- Made in
- United States
- Issuing agency
- FDA
In context
- Lupin Pharmaceuticals Inc. has 19 recalls in our database, including 1 rated Critical.
- We're tracking 3,576 Health recalls in our database.
- This is the 737th Health recall we've logged in 2024.